nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000975	0.000975	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Doxorubicin—uterine cancer	0.000973	0.000973	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Epirubicin—uterine cancer	0.000973	0.000973	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Epirubicin—uterine cancer	0.000973	0.000973	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000969	0.000969	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Progesterone—uterine cancer	0.000967	0.000967	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Epirubicin—uterine cancer	0.000953	0.000953	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Epirubicin—uterine cancer	0.00095	0.00095	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dactinomycin—uterine cancer	0.000948	0.000948	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Etoposide—uterine cancer	0.000947	0.000947	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Etoposide—uterine cancer	0.000943	0.000943	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000941	0.000941	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.000938	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Epirubicin—uterine cancer	0.000935	0.000935	CcSEcCtD
Gadobenate Dimeglumine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00093	0.00093	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000929	0.000929	CcSEcCtD
Gadobenate Dimeglumine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000924	0.000924	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Etoposide—uterine cancer	0.00092	0.00092	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Doxorubicin—uterine cancer	0.000919	0.000919	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Epirubicin—uterine cancer	0.000917	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Etoposide—uterine cancer	0.000913	0.000913	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dactinomycin—uterine cancer	0.000909	0.000909	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dactinomycin—uterine cancer	0.000909	0.000909	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000908	0.000908	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Epirubicin—uterine cancer	0.000903	0.000903	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Doxorubicin—uterine cancer	0.0009	0.0009	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Doxorubicin—uterine cancer	0.0009	0.0009	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Etoposide—uterine cancer	0.000897	0.000897	CcSEcCtD
Gadobenate Dimeglumine—Cough—Etoposide—uterine cancer	0.00089	0.00089	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Epirubicin—uterine cancer	0.00089	0.00089	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Doxorubicin—uterine cancer	0.000882	0.000882	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Etoposide—uterine cancer	0.000881	0.000881	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Doxorubicin—uterine cancer	0.000879	0.000879	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Epirubicin—uterine cancer	0.000877	0.000877	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000876	0.000876	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Etoposide—uterine cancer	0.000869	0.000869	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Doxorubicin—uterine cancer	0.000865	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000863	0.000863	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Etoposide—uterine cancer	0.000858	0.000858	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000855	0.000855	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Epirubicin—uterine cancer	0.000849	0.000849	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Doxorubicin—uterine cancer	0.000848	0.000848	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Dactinomycin—uterine cancer	0.000848	0.000848	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Etoposide—uterine cancer	0.00084	0.00084	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000838	0.000838	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—uterine cancer	0.000835	0.000835	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Etoposide—uterine cancer	0.000833	0.000833	CcSEcCtD
Gadobenate Dimeglumine—Infection—Etoposide—uterine cancer	0.000827	0.000827	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—uterine cancer	0.000825	0.000825	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000823	0.000823	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Epirubicin—uterine cancer	0.000821	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Etoposide—uterine cancer	0.000813	0.000813	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000811	0.000811	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Etoposide—uterine cancer	0.000809	0.000809	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Etoposide—uterine cancer	0.000805	0.000805	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000791	0.000791	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—uterine cancer	0.000789	0.000789	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—uterine cancer	0.000787	0.000787	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000786	0.000786	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Etoposide—uterine cancer	0.000778	0.000778	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000775	0.000775	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—uterine cancer	0.000759	0.000759	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—uterine cancer	0.000758	0.000758	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—uterine cancer	0.000748	0.000748	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—uterine cancer	0.000742	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—uterine cancer	0.00074	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—uterine cancer	0.00074	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—uterine cancer	0.000732	0.000732	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—uterine cancer	0.000732	0.000732	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—uterine cancer	0.000731	0.000731	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—uterine cancer	0.00073	0.00073	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—uterine cancer	0.000725	0.000725	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—uterine cancer	0.000719	0.000719	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000719	0.000719	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—uterine cancer	0.000718	0.000718	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—uterine cancer	0.000712	0.000712	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—uterine cancer	0.000712	0.000712	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—uterine cancer	0.000711	0.000711	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—uterine cancer	0.000711	0.000711	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—uterine cancer	0.000702	0.000702	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—uterine cancer	0.000702	0.000702	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—uterine cancer	0.000698	0.000698	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—uterine cancer	0.000686	0.000686	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000685	0.000685	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—uterine cancer	0.000683	0.000683	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—uterine cancer	0.000681	0.000681	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—uterine cancer	0.000677	0.000677	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—uterine cancer	0.000677	0.000677	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—uterine cancer	0.000669	0.000669	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—uterine cancer	0.000666	0.000666	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—uterine cancer	0.000661	0.000661	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—uterine cancer	0.000659	0.000659	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—uterine cancer	0.000658	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—uterine cancer	0.000658	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—uterine cancer	0.000658	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—uterine cancer	0.000658	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—uterine cancer	0.000654	0.000654	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—uterine cancer	0.000649	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—uterine cancer	0.000649	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—uterine cancer	0.000647	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—uterine cancer	0.000646	0.000646	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—uterine cancer	0.000646	0.000646	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—uterine cancer	0.000644	0.000644	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—uterine cancer	0.000633	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—uterine cancer	0.000619	0.000619	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—uterine cancer	0.000613	0.000613	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—uterine cancer	0.000612	0.000612	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—uterine cancer	0.00061	0.00061	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—uterine cancer	0.00061	0.00061	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—uterine cancer	0.000609	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000605	0.000605	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—uterine cancer	0.0006	0.0006	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—uterine cancer	0.000599	0.000599	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—uterine cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—uterine cancer	0.000596	0.000596	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—uterine cancer	0.000596	0.000596	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—uterine cancer	0.000593	0.000593	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—uterine cancer	0.000592	0.000592	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—uterine cancer	0.000589	0.000589	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—uterine cancer	0.000589	0.000589	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—uterine cancer	0.000587	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—uterine cancer	0.000586	0.000586	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—uterine cancer	0.000576	0.000576	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—uterine cancer	0.000572	0.000572	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—uterine cancer	0.000572	0.000572	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—uterine cancer	0.00057	0.00057	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—uterine cancer	0.000568	0.000568	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—uterine cancer	0.000567	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—uterine cancer	0.000564	0.000564	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—uterine cancer	0.000564	0.000564	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—uterine cancer	0.00056	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—uterine cancer	0.000553	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—uterine cancer	0.000551	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—uterine cancer	0.000551	0.000551	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—uterine cancer	0.00055	0.00055	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—uterine cancer	0.000549	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000548	0.000548	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—uterine cancer	0.000545	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—uterine cancer	0.000543	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—uterine cancer	0.000533	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—uterine cancer	0.000531	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—uterine cancer	0.000529	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—uterine cancer	0.000529	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—uterine cancer	0.000525	0.000525	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—uterine cancer	0.000524	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—uterine cancer	0.000522	0.000522	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—uterine cancer	0.000518	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—uterine cancer	0.000516	0.000516	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—uterine cancer	0.000513	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—uterine cancer	0.000512	0.000512	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—uterine cancer	0.000512	0.000512	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—uterine cancer	0.000509	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—uterine cancer	0.000505	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—uterine cancer	0.000503	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—uterine cancer	0.000499	0.000499	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—uterine cancer	0.000495	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—uterine cancer	0.000494	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000491	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—uterine cancer	0.000489	0.000489	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—uterine cancer	0.000487	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—uterine cancer	0.000487	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—uterine cancer	0.000487	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—uterine cancer	0.000485	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000484	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—uterine cancer	0.000481	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—uterine cancer	0.000477	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—uterine cancer	0.000476	0.000476	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—uterine cancer	0.000475	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—uterine cancer	0.000474	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—uterine cancer	0.000471	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—uterine cancer	0.000468	0.000468	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—uterine cancer	0.000467	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—uterine cancer	0.000465	0.000465	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—uterine cancer	0.000464	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—uterine cancer	0.000462	0.000462	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—uterine cancer	0.000459	0.000459	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—uterine cancer	0.000458	0.000458	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—uterine cancer	0.000457	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—uterine cancer	0.000456	0.000456	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—uterine cancer	0.000453	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—uterine cancer	0.000451	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—uterine cancer	0.00045	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—uterine cancer	0.00045	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—uterine cancer	0.00045	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—uterine cancer	0.000449	0.000449	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000447	0.000447	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—uterine cancer	0.000445	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—uterine cancer	0.000441	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—uterine cancer	0.000436	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—uterine cancer	0.000435	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000432	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—uterine cancer	0.000429	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000425	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—uterine cancer	0.000425	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—uterine cancer	0.000424	0.000424	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—uterine cancer	0.000421	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—uterine cancer	0.000419	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—uterine cancer	0.000419	0.000419	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000417	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—uterine cancer	0.000416	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—uterine cancer	0.000415	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—uterine cancer	0.000411	0.000411	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—uterine cancer	0.000404	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000403	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—uterine cancer	0.000402	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—uterine cancer	0.000399	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—uterine cancer	0.000399	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000393	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—uterine cancer	0.000388	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—uterine cancer	0.000385	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—uterine cancer	0.000385	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—uterine cancer	0.000384	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000382	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—uterine cancer	0.00038	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000373	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—uterine cancer	0.000372	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—uterine cancer	0.000371	0.000371	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—uterine cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—uterine cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—uterine cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—uterine cancer	0.000369	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—uterine cancer	0.000356	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000353	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—uterine cancer	0.000344	0.000344	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—uterine cancer	0.000343	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—uterine cancer	0.000341	0.000341	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—uterine cancer	0.000341	0.000341	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—uterine cancer	0.000335	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—uterine cancer	0.00033	0.00033	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—uterine cancer	0.000319	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—uterine cancer	0.000318	0.000318	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—uterine cancer	0.00031	0.00031	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—uterine cancer	0.000309	0.000309	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—uterine cancer	0.000306	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—uterine cancer	0.000297	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—uterine cancer	0.000295	0.000295	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—uterine cancer	0.000294	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—uterine cancer	0.000294	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—uterine cancer	0.000292	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—uterine cancer	0.000286	0.000286	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—uterine cancer	0.000277	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—uterine cancer	0.000275	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—uterine cancer	0.000272	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—uterine cancer	0.000272	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—uterine cancer	0.000271	0.000271	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—uterine cancer	0.000257	0.000257	CcSEcCtD
